Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX

Lasers in Surgery and Medicine

Volumn 39, Issue 5, 2007, Pages 386-393

  Beck, Tobias J ^a   Kreth, Friedrich W ^a   Beyer, Wolfgang ^a   Mehrkens, Jan H ^a   Obermeier, Andreas ^a   Stepp, Herbert ^a   Stummer, Walter ^b   Baumgartner, Reinhold ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

5 aminolevulinic acid; Brain tumor; Cylindrical diffuser; Dosimetry; Glioblastoma; Interstitial; Intratumoral; Light application; Neurosurgery; Photodynamic therapy; Protoporphyrin IX; Stereotactic

Indexed keywords

AMINOLEVULINIC ACID; FLUORINE 18; O (2 FLUOROETHYL)TYROSINE F 18; PROTOPORPHYRIN; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FEASIBILITY STUDY; GLIOBLASTOMA; HEAT TRANSFER; HUMAN; INTERSTITIAL PHOTODYNAMIC THERAPY; LIGHT; MONTE CARLO METHOD; NEUROSURGERY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PILOT STUDY; PRIORITY JOURNAL; RADIATION DOSE; REPRODUCIBILITY; SAFETY; STEREOTAXIC SURGERY; SURVIVAL TIME; TREATMENT PLANNING;

ADULT; AGED; AMINOLEVULINIC ACID; BRAIN NEOPLASMS; FEASIBILITY STUDIES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MONTE CARLO METHOD; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; PROTOPORPHYRINS; RADIOSURGERY;

EID: 34447257445     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20507     Document Type: Article

References (43)

1. Shapiro WR, Green SB, Burger PC, Mahaley MS Jr, Selker RG, VanGilder JC, Robertson JT, Ransohoff J, Mealey J, Jr., Strike TA. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989;71:1-9.
2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
3. Bashir R, Hochberg F, Oot R. Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields. Neurosurgery 1988;23:27-30.
4. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45-60.
5. Kostron H, Obwegeser A, Jakober R. Photodynamic therapy in neurosurgery: A review. J Photochem Photobiol B 1996;36:157-168.
6. Popovic EA, Kaye AH, Hill JS. Photodynamic therapy of brain tumors. J Clin Laser Med Surg 1996;14:251-261.
7. Muller PJ, Wilson BC. Photodynamic therapy of malignant brain tumours. Can J Neurol Sci 1990;17:193-198.
8. Muller PJ, Wilson BC. Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. J Clin Laser Med Surg 1996;14:263-270.
9. Origitano TC, Caron MJ, Reichman OH. Photodynamic therapy for intracranial neoplasms. Literature review and institutional experience. Mol Chem Neuropathol 1994;21:337-352.
10. Stylli SS, Kaye AH, Macgregor L, Howes M, Rajendra P. Photodynamic therapy of high grade glioma - long term survival. J Clin Neurosci 2005;12:389-398.
11. Lilge L, Olivo MC, Schatz SW, MaGuire JA, Patterson MS, Wilson BC. The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy. Br J Cancer 1996;73:332-343.
12. Hebeda KM, Kamphorst W, Sterenborg HJCM, Wolbers JG. Damage to tumour and brain by interstitial photodynamic therapy in the 9L rat tumour model comparing intravenous and intratumoral administration of the photosensitiser. Acta Neurochir 1998;140:495-501.
13. Powers SK, Cush SS, Walstad DL, Kwock L. Stereotaxic intratumoral photodynamic therapy for recurrent malignant brain-tumors. Neurosurgery 1991;29:688-696.
14. Origitano TC, Reichman OH. Photodynamic therapy for intracranial neoplasms: Development of an image-based computer-assisted protocol for photodynamic therapy of intracranial neoplasms. Neurosurgery 1993;32:587-595.
15. Krishnamurthy S, Powers SK, Witmer P, Brown T. Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors. Lasers Surg Med 2000;27:224-234.
16. Schmidt MH, Meyer GA, Reichert KW, Cheng J, Krouwer HG, Ozker K, Whelan HT. Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors. J Neurooncol 2004;67:201-207.
17. Olzowy B, Hundt CS, Stocker S, Bise K, Reulen HJ, Stummer W. Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. J Neurosurg 2002;97:970-976.
18. Madsen SJ, Sun CH, Tromberg BJ, Wallace VP, Hirschberg H. Photodynamic therapy of human glioma spheroids using 5- aminolevulinic acid. Photochem Photobiol 2000;72:128-134.
19. Hirschberg H, Sun CH, Tromberg BJ, Madsen SJ. ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids. J Neurooncol 2002;57:1-7.
20. Madsen SJ, Sun CH, Tromberg BJ, Hirschberg H. Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids. J Neurooncol 2003;62:243-250.
21. Friesen SA, Hjortland GO, Madsen SJ, Hirschberg H, Engebraten O, Nesland JM, Peng Q. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (Review). Int J Oncol 2002;21:577-582.
22. Stepp H, Beck T, Beyer W, Pongratz T, Sroka R, Baumgartner R, Stummer W, Olzowy B, Mehrkens JH, Tonn JC, Reulen HJ. Fluorescence-guided resections and photodynamic therapy for malignant gliomas using 5-aminolevulinic acid. Proc SPIE 2005;5686:547-557.
23. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, Reulen HJ. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 1998;42:518-525.
24. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5- aminolevulinic acid-induced porphyrins: A prospective study in 52 consecutive patients. J Neurosurg 2000;93:1003-1013.
25. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol 2006;7:392-401.
26. Laser- und Medizin-Technologie gGmbH B. LITCIT: Technical Reference Manual; Version 4.8. LMTB 1998.
27. Beck TJ, Beyer W, Pongratz T, Stummer W, Waidelich R, Stepp H, Wagner S, Baumgartner R, Clinical determination of tissue optical properties in vivo by spatially resolved reflectance measurements. Proc SPIE 2003;5138:96-105.
28. Muller PJ, Wilson BC. An update on the penetration depth of 630 nm light in normal and malignant human brain tissue in vivo. Phys Med Biol 1986;31:1295-1297.
29. Wilson BC, Muller PJ. Instrumentation and light dosimetry for intraoperative photodynamic therapy (PDT) of malignant brain-tumors. Phys Med Biol 1986;31:125-133.
30. Prahl SA, Keijzer M, Jacques SL, Welch AJ. A Monte Carlo model of light propagation in tissue. In: Dosimetry of laser radiation in medicine and biology, Mueller G, Sliney D, Eds., SPIE Institute Series. 1989; IS 5:102-111.
31. Curnow A, Haller JC, Bown SG. Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. J Photochem Photobiol B 2000;58:149-155.
32. Pogue BW, O'Hara JA, Goodwin IA, Wilmot CJ, Fournier GP, Akay AR, Swartz H, Tumor PO2 changes during photodynamic therapy depend upon photosensitizer type and time after injection. Comp Biochem Physiol A Mol Integr Physiol 2002;132:177-184.
33. Chen Q, Chopp M, Madigan L, Dereski MO, Hetzel FW. Damage threshold of normal rat brain in photodynamic therapy. Photochem Photobiol 1996;64:163-167.
34. Dereski MO, Chopp M, Chen Q, Hetzel FW. Normal brain-tissue response to photodynamic therapy - histology, vascular-permeability and specific-gravity. Photochem Photobiol 1989;50:653-657.
35. Whelan HT, Schmidt MH, Segura AD, McAuliffe TL Bajic DM, Murray KJ, Moulder JE, Strother DR, Thomas JP, Meyer GA. The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. J Neurosurg 1993;79:562-568.
36. Stummer W, Gotz C, Hassan A, Heimann A, Kempski O. Kinetics of Photofrin II in perifocal brain edema. Neurosurgery 1993;33:1075-1081.
37. Stummer W, Hassan A, Kempski O, Goetz C. Photodynamic therapy within edematous brain tissue: Considerations on sensitizer dose and time point of laser irradiation. J Photochem Photobiol B 1996;36:179-181.
38. Ericson MB, Sandberg C, Stenquist B, Gudmundson F, Karlsson M, Ros AM, Rosen A, Larko O, Wennberg AM, Rosdahl I. Photodynamic therapy of actinic keratosis at varying fluence rates: Assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 2004;151:1204-1212.
39. Johansson T, Thompson MS, Stenberg M, af Klinteberg C, Engels SA, Svanberg S, Svanberg K. Feasibility study of a system for combined light dosimetry and interstitial photodynamic treatment of massive tumors. Applied Optics 2002;41:1462-1468.
40. Thompson MS, Johansson A, Johansson T, Andersson-Engels S, Svanberg S, Bendsoe N, Svanberg K. Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. Appl Opt 2005;44:4023-4031.
41. van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 2003;207:105-113.
42. Jalili A, Makowski M, Switaj T, Nowis D, Wilczynski GM, Wilczek E, Chorazy-Massalska M, Radzikowska A, Maslinski W, Bialy L, Sienko J, Sieron A, Adamek M, Basak G, Mroz P, Krasnodebski IW, Jakobisiak M, Golab J. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res 2004;10:4498-4508.
43. Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res 2005;65:1018-1026.